Gabapentin
Product Images NDC 53002-6423

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 53002-6423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

The text is providing information regarding a study on pain management. It includes data on mean pain scores and the dosage of medication given in two different treatment periods; dose titration period and fixed dose period. The study compares the effects of placebo and gabapentin, with a dosage of 3600mg/day. The data is presented for baseline and several weeks.*

FDA Label Image

Figure 2 (Image 02)

This text describes the results of a study with different doses of Gabapentin and Placebo for pain relief over a period of 4 weeks. It includes a graph with the mean pain score over time and different treatment groups.*

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Label Image (Lbl530026423)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.